{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:17:50Z","timestamp":1788347870278,"version":"build-2803163510"},"reference-count":21,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,8,23]],"date-time":"2006-08-23T00:00:00Z","timestamp":1156291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2006,10]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:<\/jats:bold>\n                    To evaluate the effectiveness of blood donor selection, this study reports risk profiles of donors with transfusion\u2010transmissible infections as obtained by ongoing surveillance, 1995 through 2003, in the Netherlands.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold>\n                    A surveillance program was installed to monitor risk profiles among new and repeat donors infected with human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), or human T\u2010lymphotropic virus (HTLV), or positive for the presence of syphilis antibodies. At posttest counseling, a physician interviewed donors to clarify possible sources of infection.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    A total of 167 repeat donors and 404 new donors were interviewed: 33 with HIV, 123 with HCV, 279 with HBV, 21 with HTLV, and 112 with syphilis antibodies. Most HBV, HCV, and HTLV infections were among new donors (80, 85, and 67%), whereas most HIV infections were among repeat donors (79%). Nearly 25\u2003percent of the donors did not report factors at screening that would have deferred them from donating blood. At posttest interviews, new donors with HCV often reported injecting drug use (19%). Repeat donors with HIV often reported male\u2010to\u2010male sex (8\/26, 31%).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    A significant level of deferrable behavioral risks was found among donors with confirmed transfusion\u2010transmissible infections that persist despite current donor selection. Reporting such behavior at initial donor selection would have eliminated a substantial part of the infections found. This study argues against relaxing the existing donor deferral of persons practicing male\u2010to\u2010male sex, given their significant proportion of HIV infections among repeat donors. Systematic surveillance of risk factors among infected blood donors provides ongoing information about the effectivity of donor selection and is recommended to evaluate and optimize blood policies.\n                  <\/jats:p>","DOI":"10.1111\/j.1537-2995.2006.00964.x","type":"journal-article","created":{"date-parts":[[2006,8,23]],"date-time":"2006-08-23T11:01:22Z","timestamp":1156330882000},"page":"1729-1736","source":"Crossref","is-referenced-by-count":42,"title":["Surveillance of risk profiles among new and repeat blood donors with transfusion\u2010transmissible infections from 1995 through 2003 in the Netherlands"],"prefix":"10.1111","volume":"46","author":[{"given":"Akke K.","family":"Van der Bij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel A.","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees L.","family":"Van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,9,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906013202205"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2257.2000.00265.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)06318-1"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37197176950.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342601"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05464.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.03421.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540360035027"},{"key":"e_1_2_7_10_2","volume-title":"Guidelines for laboratory testing of infectious diseases [In dutch].","year":"1994"},{"key":"e_1_2_7_11_2","volume-title":"Guidelines for laboratory testing of infectious diseases [in Dutch].","year":"2003"},{"key":"e_1_2_7_12_2","volume-title":"Council Recommendation of 29 June 1998 on the suitability of blood and plasma donors and the screening of donated blood in the European community.","year":"1998"},{"key":"e_1_2_7_13_2","volume-title":"Guideline donor selection [in Dutch].","year":"2001"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.2.229"},{"key":"e_1_2_7_15_2","volume-title":"Prevalence of hepatitis B viral markers in the dutch population: a population\u2010based serosurveillance study (Pienter Project)","author":"Marrewijk CM","year":"2000"},{"key":"e_1_2_7_16_2","volume-title":"STI and HIV in the Netherlands [in Dutch].","author":"Laar MJ","year":"2000"},{"key":"e_1_2_7_17_2","first-page":"29S","article-title":"Evaluation of donors who primarily give for HIV testing","volume":"41","author":"Schreiber GB","year":"2001","journal-title":"Transfusion"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41111341.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342602"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.00623.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00473.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2003.00295.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1537-2995.2006.00964.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1537-2995.2006.00964.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:45:59Z","timestamp":1695948359000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1537-2995.2006.00964.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,21]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["10.1111\/j.1537-2995.2006.00964.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1537-2995.2006.00964.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,21]]}}}